| [1] |
Hematology Section of the Pediatrics Branch at the Chinese Medical Association, Editorial board of Chinese Journal of Pediatrics. Diagnosis and treatment of pediatric acute lymphoblastic leukemia (3rd revised)[J]. Zhonghua Er Ke Za Zhi, 20 06, 44(5): 392-5. [中华医学会儿科学分会血液学组,中华儿科 杂志编辑委员会. 儿童急性淋巴细胞白血病诊疗建议(第三次 修订草案) [J]. 中华儿科杂志, 2006, 44(5): 392-5.]
|
| [2] |
Ye H, Gu LJ, Chen J, et al. High dose methotrexate therapy in childhood acute lymphoblastic leukemia[J]. Zhonghua Xue Ye Xue Za Zhi, 2001, 22(7): 385-6. [叶辉, 顾龙君, 陈静, 等. 儿童急 性淋巴细胞白血病大剂量甲氨蝶呤治疗研究[J]. 中华血液学杂 志, 2001, 22(7): 385-6.]
|
| [3] |
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury[J]. Kidney Int, 2012, 2(1 Suppl): 1-138.
|
| [4] |
Pang L, Liu LM, Zhao LM. Research progress in influence factorsof excretion delay of high-dose methotrexate[J]. Zhongguo Yao Xue Za Zhi, 2013, 48(22): 1892-6. [庞露, 刘立民, 肇丽梅. 大剂 量甲氨蝶呤排泄延迟影响因素的研究进展[J]. 中国药学杂志, 20 13, 48(22): 1892-6.]
|
| [5] |
Takeda M, Khamdang S, Narikawa S, et al. Characterization of methotrexate transport and its drug interactions with human organic anion transporters[J]. J Pharmacol Exp Ther, 2002, 30 2(2): 666-71.
|
| [6] |
Zarychanski R, Wlodarczyk K, Ariano R, et al. Pharmacokinetic interaction between methotrexate and piperacillin/tazobactam resulting in prolonged toxic concentrations of methotrexate[J]. J Antimicrob Chemother, 2006, 58(1): 228-30.
|
| [7] |
El-Sheikh AA, van den Heuvel JJ, Koenderink JB, et al. Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport[J]. J Pharmacol Exp Ther, 2007, 320(1): 22 9-35.
|
| [8] |
Skeith KJ, Russell AS, Jamali F, et al. Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis[J]. J Rheumatol, 1990, 17(8): 1008-10.
|
| [9] |
Breedveld P, Zelcer N, Pluim D, et al. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions[J]. Cancer Res, 2004, 64(16): 58 04-11.
|
| [10] |
Perazella MA. Crystal-induced acute renal failure[J]. Am J Med, 19 99, 106(4): 459-65.
|
| [11] |
Li D, Li XZ. Therapeutic effect of hemodialysis on acute kidney injury induced by high-dose methotrexate chemotherapy in children[J]. Shi Yong Er Ke Lin Chuang Za Zhi, 2012, 27(17): 13 20-2. [李迪, 李晓忠. 血液透析治疗大剂量甲氨蝶呤化疗 所致急性肾损伤的疗效[J]. 实用儿科临床杂志, 2012, 27(17): 13 20-2.]
|
| [12] |
Xu WQ, Tang YM, Fang CQ, et al. Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia[J]. Zhonghua Xue Ye Xue Za Zhi, 2005, 26(1): 15-8. [徐卫群, 汤永民, 方澄清, 等. 大剂量甲氨蝶呤治疗儿童急性淋 巴细胞白血病排泄延迟分析[J]. 中华血液学杂志, 2005, 26(1): 15 -8.]
|
| [13] |
Lu H, Zhong XB, Huang ZG, et al. Elimination delay of high-dose methotrexate in children with acute lymphoblastic leukemia[J]. Zhongguo Yao Fang, 2009, 20(29): 2265-8. [陆华, 钟小斌, 黄振 光, 等. 大剂量甲氨蝶呤治疗儿童急性淋巴细胞白血病排泄延 迟分析[J]. 中国药房, 2009, 20(29): 2265-8.]
|
| [14] |
Meng LY, Tian HP, Wang XJ, et al. The effect of MTHFR gene polymorphism in the toxic side effects of HD-MTX chemotherapy on children[J]. Er Ke Yao Xue Za Zhi, 2013, 19(2): 1-4. [孟琳懿, 田怀平, 王小洁, 等. 亚甲基四氢叶酸还原酶基因多态性对儿童 甲氨蝶呤化疗后毒副反应[J]. 儿科药学杂志, 2013, 19(2): 1-4.]
|
下载:
